Hydrogenology
Hydrogenology editorial study record

Hydrogen-Rich Water Ameliorates Metabolic Disorder via Modifying Gut Microbiota in Impaired Fasting Glucose Patients: A Randomized Controlled Study

Liang B et al. · Antioxidants (Basel). 2023;12(6):1245.

HumanH₂-rich waterPublished 2023
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Human

Reported design

Randomized double-blind placebo-controlled parallel trial

Research topic

Metabolic and lipid health

Administration classification

H₂-rich water

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Adults with impaired fasting glucose

Sample

73 analyzed: H₂ water n=32; pure water n=41

Duration

8 weeks

Intervention

Hydrogen-rich water, 1,000 mL/day

Hydrogen form

H₂ dissolved in water — H₂ only, not Brown’s gas.

H₂ specification

The article text reports 1.6 mg/mL and a 1.4 mg/mL requirement, while its supplementary figure uses mg/L. Hydrogenology does not resolve this internal unit inconsistency without author clarification.

H₂ flow

Not applicable — oral water, not gas inhalation.

O₂ delivered with H₂

No O₂ was co-delivered as part of the intervention.

Comparator

1,000 mL/day pure water with no H₂ infusion

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Fasting glucose, normalization of glucose, liver-fat and visceral-fat measures, body weight, gut microbiota and metabolomics

Reported result

Both groups had lower fasting glucose; the between-group result favored H₂ water. Glucose normalization was 68.8% versus 53.8% and was not statistically significant. In the abnormal-fatty-liver subset, remission was 10/16 versus 6/19; microbiome and metabolomic analyses were exploratory.

Results-extraction completeness

Methods, main results, funding and conflict statement checked in the free full text. The concentration unit discrepancy remains unresolved.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Twenty-six participants were lost between enrollment and analysis; subgroup and microbiome samples were smaller. The authors describe the metabolic effect as slight. Public Chinese grants funded the work and no conflict was declared.

Applies directly to

Adults with impaired fasting glucose under this eight-week protocol.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 37371975 · DOI: 10.3390/antiox12061245

Publisher access

Open-access article.

Extraction basis

Free full text on PMC and publisher page; identifiers cross-checked in PubMed.

Record revision

2026-08-10